You mistake what I'm saying in response to very specific posts you made about NWBO, with what might be happening with another company under completely different circumstances.
I did not say that funds NEVER invest in biotech direct offerings. Go back and look. I even gave an example of a fund complex that does it regularly, Franklin. I am familiar with Args, and yes, they don't have the same issues as NWBO. Nor does their fund investor have likely the same issues as NW.
You take general situations and extrapolate them without the facts. My point was only that uninformed speculation about NW's actual reasons for NOT doing things that you want him to do, based upon some other investment you have, is not really very informative.
I agree with you that ARGS has not been subject to short attack and is in a different situation.
In my experience, shorts attack companies that are being pursued for takeover. Or at least that is how it starts, and usually how it ends. We'll see.
The one asset that NWBO has is LP, though I know she's unpopular with some, maybe even you. The purpose of the shorts is to destroy her credibility and connection to the company, so it can be taken over, even though most probably don't actually know that is their purpose and they are just there for a free meal and to ride along with the pack.
It's kind of limited utility to go on discussing ARGS in relation to what you think should happen with NWBO. Sure, a fund could step up. NW is likely not in a great position to be the one stepping up. He may do so once there is more data available or something substantially changes to allow him to do so. One issue also, is the NASDAQ matter.
Again, funds are not there to SAVE your personal investment. They are there for their own reasons, the managers have duties to their own investors, and they don't just act because they feel like doing so... they have parameters and other guidelines. If and when NWBO fits such guidelines, then sure, there may be some funds that DIRECTLY invest.
Or there may not be.
Again there are funds that typically do that, and funds that don't. Some have limited amounts of their portfolio set aside for certain kinds of investments, they typically don't go all in. The discussion around here relating to NW and how he relates to the company are simply too broadly speculative, seem ill informed about the nature of things, and kind of manipulative, though I don't think intentionally so, but most likely derived from some sort of emotional desire to be vindicated or something like that...
Again, I didn't say he WON"T EVER, just that the speculation about what his motives are, and what he will and won't do and why that is... is mostly ill informed and speculative, and in some posts, based upon grossly inaccurate assumptions that no doubt can be cleaned up on subsequent posts and redirected.
Also, you're all over the place on direct investment (money goes directly to the company in an offering), and price support by buying in the open secondary market, a whole other matter. Let's not confuse all of these things into a big mess of general :"funds" talk, when we know there are many different KINDS of "funds" with different investment objectives, regulations, and portfolios. Yes, they do tend to invest in companies that look like they are moving up, and only special funds tend to target more "distressed" companies. I'd say that NWBO, because of the steady short attacks over the years, is more the latter, though hopefully soon it will no longer be in that position. It seems to many, there is clearly great value here that the market misperceives. There are funds and investors for that kind of investment, though they also tend not to be the best sort. Let's hope, with news, they won't need that sort of investor.
AI
